ZHU Xun

ZHU Xun, listed as chief executive, has filed trades across 2 companies (mainly through HKEX), most often in HighTide Therapeutics, Inc. - B and Sihuan Pharmaceutical Holdings Group Ltd. The record holds 6 filings, for trades running from 26 August 2020 to 1 April 2026.

Purchases make up the whole of the open-market record (1 purchase). The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

Most recently, on 8 April 2026, the filings show a transaction in HighTide Therapeutics, Inc. - B. The last insider purchase was made public on 31 August 2020, 2,246 days ago. Between a trade and the moment it shows up on HKEX, the median delay is 7 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.